NASDAQ:OMCL

Omnicell Stock Forecast, Price & News

$137.84
+0.97 (+0.71 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$136.03
Now: $137.84
$139.98
50-Day Range
$122.02
MA: $133.40
$143.90
52-Week Range
$56.16
Now: $137.84
$146.00
Volume198,542 shs
Average Volume412,070 shs
Market Capitalization$5.95 billion
P/E Ratio158.44
Dividend YieldN/A
Beta1.04
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Omnicell logo

Industry, Sector and Symbol

Industry Electronic computers
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:OMCL
CUSIP68213N10
Phone650-251-6100
Employees2,860
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$897.03 million
Cash Flow$4.47 per share
Book Value$20.16 per share

Profitability

Net Income$61.34 million

Miscellaneous

Market Cap$5.95 billion
Next Earnings Date4/29/2021 (Confirmed)
OptionableOptionable

Headlines

Why Omnicell's CEO Puts Progress Over Politics
April 15, 2021 |  finance.yahoo.com
Omnicell (NASDAQ:OMCL) Stock Price Down 5%
March 30, 2021 |  americanbankingnews.com
See More Headlines

MarketRank

Overall MarketRank

1.54 out of 5 stars

Medical Sector

463rd out of 2,024 stocks

Electronic Computers Industry

4th out of 13 stocks

Analyst Opinion: 1.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
$137.84
+0.97 (+0.71 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OMCL News and Ratings via Email

Sign-up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Omnicell (NASDAQ:OMCL) Frequently Asked Questions

Is Omnicell a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Omnicell in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Omnicell stock.
View analyst ratings for Omnicell
or view top-rated stocks.

What stocks does MarketBeat like better than Omnicell?

Wall Street analysts have given Omnicell a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Omnicell wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Omnicell's next earnings date?

Omnicell is scheduled to release its next quarterly earnings announcement on Thursday, April 29th 2021.
View our earnings forecast for Omnicell
.

How can I listen to Omnicell's earnings call?

Omnicell will be holding an earnings conference call on Thursday, April 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Omnicell's earnings last quarter?

Omnicell, Inc. (NASDAQ:OMCL) issued its earnings results on Sunday, January, 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.66 by $0.25. The firm had revenue of $249.20 million for the quarter. Omnicell had a net margin of 4.25% and a trailing twelve-month return on equity of 7.96%.
View Omnicell's earnings history
.

How has Omnicell's stock been impacted by Coronavirus?

Omnicell's stock was trading at $77.41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, OMCL stock has increased by 78.1% and is now trading at $137.84.
View which stocks have been most impacted by COVID-19
.

What guidance has Omnicell issued on next quarter's earnings?

Omnicell issued an update on its FY21 earnings guidance on Monday, February, 1st. The company provided EPS guidance of $3.40-3.60 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.45. The company issued revenue guidance of $1.085-1.105 billion, compared to the consensus revenue estimate of $1.09 billion.

What price target have analysts set for OMCL?

7 brokers have issued 12 month price objectives for Omnicell's shares. Their forecasts range from $84.00 to $155.00. On average, they anticipate Omnicell's stock price to reach $118.83 in the next twelve months. This suggests that the stock has a possible downside of 13.8%.
View analysts' price targets for Omnicell
or view top-rated stocks among Wall Street analysts.

Who are Omnicell's key executives?

Omnicell's management team includes the following people:
  • Mr. Randall A. Lipps, Founder, Exec. Chairman, Pres & CEO (Age 64, Pay $2.28M)
  • Mr. Peter J. Kuipers, Exec. VP & CFO (Age 49, Pay $1.1M)
  • Mr. Daniel S. Johnston, Exec. VP, Chief Legal & Admin. Officer and Corp. Sec. (Age 57, Pay $859.1k)
  • Mr. Scott Peter Seidelmann, Exec. VP & Chief Commercial Officer (Age 45, Pay $1.05M)
  • Mr. Joseph Brian Spears, Sr. VP, Chief Accounting Officer & Corp. Controller (Age 61)
  • Mr. Giri Chodavarapu, Sr. VP & Chief Information Officer
  • Ms. Kathleen Nemeth, VP of Investor Relations
  • Ms. Christine Mellon, Exec. VP & Chief People Officer
  • Mr. Jorge R. Taborga, Exec. VP of Engineering & Integration Management Officer (Age 62)
  • Ms. Diane Kaye, Sr. VP & Chief Product Officer

What is Randall A. Lipps' approval rating as Omnicell's CEO?

150 employees have rated Omnicell CEO Randall A. Lipps on Glassdoor.com. Randall A. Lipps has an approval rating of 68% among Omnicell's employees.

Who are some of Omnicell's key competitors?

What other stocks do shareholders of Omnicell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Omnicell investors own include AT&T (T), AbbVie (ABBV), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Adobe (ADBE), Micron Technology (MU), NVIDIA (NVDA), Applied Materials (AMAT), Alibaba Group (BABA) and Intel (INTC).

What is Omnicell's stock symbol?

Omnicell trades on the NASDAQ under the ticker symbol "OMCL."

Who are Omnicell's major shareholders?

Omnicell's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Scout Investments Inc. (0.61%), State of Alaska Department of Revenue (0.07%), Louisiana State Employees Retirement System (0.05%), DnB Asset Management AS (0.03%), Everence Capital Management Inc. (0.01%) and Crossmark Global Holdings Inc. (0.01%). Company insiders that own Omnicell stock include Dan S Johnston, Joanne B Bauer, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps, Robin Gene Seim and Scott Peter Seidelmann.
View institutional ownership trends for Omnicell
.

Which major investors are selling Omnicell stock?

OMCL stock was sold by a variety of institutional investors in the last quarter, including DnB Asset Management AS, State of Alaska Department of Revenue, and Private Capital Group LLC. Company insiders that have sold Omnicell company stock in the last year include Randall A Lipps, Robin Gene Seim, and Scott Peter Seidelmann.
View insider buying and selling activity for Omnicell
or view top insider-selling stocks.

Which major investors are buying Omnicell stock?

OMCL stock was bought by a variety of institutional investors in the last quarter, including Scout Investments Inc., Everence Capital Management Inc., Crossmark Global Holdings Inc., Veriti Management LLC, Louisiana State Employees Retirement System, and FDx Advisors Inc..
View insider buying and selling activity for Omnicell
or or view top insider-buying stocks.

How do I buy shares of Omnicell?

Shares of OMCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Omnicell's stock price today?

One share of OMCL stock can currently be purchased for approximately $137.84.

How much money does Omnicell make?

Omnicell has a market capitalization of $5.95 billion and generates $897.03 million in revenue each year. The company earns $61.34 million in net income (profit) each year or $2.19 on an earnings per share basis.

How many employees does Omnicell have?

Omnicell employs 2,860 workers across the globe.

What is Omnicell's official website?

The official website for Omnicell is www.omnicell.com.

Where are Omnicell's headquarters?

Omnicell is headquartered at 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043.

How can I contact Omnicell?

Omnicell's mailing address is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The company can be reached via phone at 650-251-6100 or via email at [email protected]


This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.